As of 2024-12-14, the Intrinsic Value of Nirvana Life Sciences Inc (NIRV.CN) is
-1.40 CAD. This NIRV.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.08 CAD, the upside of Nirvana Life Sciences Inc is
-1,960.83%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.40 CAD
Intrinsic Value
NIRV.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.40 - -1.40 |
-1.40 |
-1,960.83% |
| DDM - Stable |
(1.30) - (2.58) |
(1.94) |
-2687.5% |
| DDM - Multi |
(1.34) - (2.08) |
(1.63) |
-2273.5% |
NIRV.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.33 |
| Beta |
2.57 |
| Outstanding shares (mil) |
4.40 |
| Enterprise Value (mil) |
0.35 |
| Market risk premium |
5.10% |
| Cost of Equity |
16.37% |
| Cost of Debt |
5.00% |
| WACC |
14.47% |